Skip to main content

Advertisement

Figure 2 | Cancer Cell International

Figure 2

From: The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis

Figure 2

Morphological examination of the effects of ATO and nilotinib on cell differentiation. Cells were treated with 1 μM ATO and 5 nM nilotinib alone or in combination for 72 h. The cells were stained with Wright-Giemsa, and cell morphology was examined under light microscope at 1000x magnification.

Back to article page